Atlas Trials

Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft

Clinical trial NCT03887156 · UNKNOWN

Trial details

NCT number
NCT03887156
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Acute Myeloid Leukemia in RemissionLymphoma in RemissionNon-progressive Myeloproliferative SyndromeMyelodysplasia With Stable Blasts is Cell Number and < 10% of BlastocystsAcute Leukemia Biphenotypic in RemissionAcute Lymphoblastic Leukemia
Start date
2019-09-16
Primary completion
2023-03-16
Enrollment
227

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.